Target intelligence / Profile preview

High mobility group box 2 pseudogene 1 (HMGB2P1)

Target
HMGB2P1
Molecular classification
Pseudogene
01

Overview

High mobility group box 2 pseudogene 1 (HMGB2P1) is classified as a pseudogene—a genomic sequence similar to the high mobility group box 2 (HMGB2) gene, but lacking protein-coding capability and evidence for direct transcription or translation[6]. Pseudogenes often arise from duplication or retrotransposition events, and typically do not produce functional proteins. Some pseudogenes can have regulatory effects on their parent gene via RNA-mediated mechanisms, but no such function is documented for HMGB2P1[2][4]. HMGB2P1 should not be confused with HMGB2, which is a functional chromatin-associated protein involved in transcription and DNA repair, and is a potential therapeutic target[3]. No drugs, disease associations, or biomarker applications have been reported for HMGB2P1, and it is not described as a receptor, enzyme, or functional target in human physiology or pharmacology[6]. In summary, HMGB2P1 is a non-functional pseudogene with no established biological or therapeutic role. Use of HMGB2P1 as a biomedical target is incorrect.

Other names
High mobility group box 2 pseudogene 1HMGB2P1HMGB2 pseudogene 1 (rare)

Beyond the preview

Go deeper on High mobility group box 2 pseudogene 1 (HMGB2P1).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on High mobility group box 2 pseudogene 1 (HMGB2P1).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call